About PELVIPHARM
PELVIPHARM is a company based in Versailles (France) founded in 1999. It operates as a B2B. PELVIPHARM offers products and services including Preclinical Research Services, In Vivo Testing, and Ex Vivo Testing. PELVIPHARM operates in a competitive market with competitors including AlphaLab Health, Wickham Laboratories, cGMP Validation, Rubizon and NexAge Technologies, among others.
- Headquarter Versailles, France
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pelvipharm.com
- Social LinkedIn
Products & Services of PELVIPHARM
PELVIPHARM offers a comprehensive portfolio of products and services, including Preclinical Research Services, In Vivo Testing, and Ex Vivo Testing.
Provides experimental models for urogenital and gynecological studies
Conducts animal-based tests for hypertension and diabetes models
Performs tissue-based analysis for prostate and bladder research
Competitors of PELVIPHARM
PELVIPHARM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AlphaLab Health, Wickham Laboratories, cGMP Validation, Rubizon and NexAge Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| alphalabhealth.org | 2021 | Pittsburgh, United States | – | – | Market research for pharmaceuticals is provided by AlphaLab Health. | |
| wickhamlabs.co.uk | 1962 | Gosport, United Kingdom | – | – | Provider of medical device & pharmaceutical product testing services | |
| cgmpvalidation.com | 1997 | Kansas, United States | – | 24 | Offers validation, compliance, and consulting services for life sciences sectors. | |
| rubizon.com | 2017 | Bengaluru, India | – | – | Provider of clinical process development, verification, analytical, quality management and regulatory services | |
| nexageusa.com | 1999 | East Brunswick, United States | – | – | Regulatory compliance, quality assurance, and data analytics services are provided. | |
| pharma-sys.com | 1998 | Cary, United States | – | – | Provider of process validation, audit, and compliance solutions for biopharma sector | |
| marblemed.com | 1988 | Tallahassee, United States | – | – | Manufacturing validation services are provided for the biopharma sector. |
Detailed competitors of PELVIPHARM
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PELVIPHARM
Websites that share an audience with PELVIPHARM (pelvipharm.com).
Websites whose visitors overlap most with PELVIPHARM. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| panlab.com | 85% | 3.7K | – | View details |
Similar companies to PELVIPHARM
10 companies that operate in the same segment as PELVIPHARM (Genitourinary Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | – | – | |
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Miniaturized injectable neuromodulation devices are developed for chronic diseases. | 2014 | Santa Clara, California, United States | USD 123.59 M | – | – | |
Developer of a therapeutic solution to treat prostate, kidney, and bladder cancer | 2018 | Maple Grove, Minnesota, United States | USD 157 M | – | 29 | |
A device is developed to treat urinary obstruction from BPH. | 2014 | Palo Alto, California, United States | USD 48 M | – | 25 | |
Minimally invasive devices in urology | 2004 | Mountain View, California, United States | USD 137.96 M | – | 119 | |
Diagnostic devices for lower urinary tract diseases are developed. | 2021 | Aliso Viejo, California, United States | USD 94.99 M | – | 23 | |
Medical device for benign prostatic hyperplasia treatment is developed. | 2021 | Milwaukee, Wisconsin, United States | USD 54.16 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PELVIPHARM
PELVIPHARM was founded in 1999.
PELVIPHARM is headquartered in Versailles, France. It is registered at Versailles, Ile-de-france, France.
Pelvipharm is a preclinical contract research organization specializing in urogenital and gynecological research. They conduct studies using various experimental models for conditions like sexual dysfunctions, overactive bladder, endometriosis, and hypertension. Based in Montigny-Le-Bretonneux, France, they serve pharmaceutical and medical clients with expertise in pathophysiology and pharmacology. Their services include in vivo and ex vivo testing to support drug development.
PELVIPHARM's top competitors include NexAge Technologies, AlphaLab Health and Rubizon.
PELVIPHARM offers Preclinical Research Services, In Vivo Testing, and Ex Vivo Testing.